Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00587002 · ClinicalTrials.gov registry record · NA

Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction

A NA study of Myocardial Infarction, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT00587002: Completed NA study of Myocardial Infarction, sponsored by Mayo Clinic.

NCT00587002 is a NA study of Myocardial Infarction that has completed, run by Mayo Clinic. The registered enrollment target is 65 participants, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00587002, a NA study of Myocardial Infarction, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The broad objective is to advance our understanding of both in vivo anatomical and functional changes that are present in the coronary arteries in women who have an acute coronary syndrome. Specific focus will be placed on the age of the women as there may be distinct differences in younger women (\< 50 years) given the marked increase in mortality in this population.

Conditions Studied

Interventions

  • PROCEDURE IVUS

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2007-03
Est. Completion 2010-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT00587002

The ClinicalTrials.gov registry entry for NCT00587002 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which IVUS is the first listed.

NCT00587002 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00587002 about?

NCT00587002 is a clinical study titled "Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction". The broad objective is to advance our understanding of both in vivo anatomical and functional changes that are present in the coronary arteries in women who have an acute coronary syndrome. Specific focus will be placed on the age of the women as there may be distinct differences in younger women (\...

What is the current status of trial NCT00587002?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2007-03. Estimated completion is 2010-12.

What conditions does trial NCT00587002 study?

This clinical trial studies the following conditions: Myocardial Infarction.

What interventions are being tested in trial NCT00587002?

The interventions under investigation include: IVUS (PROCEDURE).

Who is sponsoring clinical trial NCT00587002?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00587002 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.